Location: Home
  • search
  • go
  • Relate News
  • 3/2/2026WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform
  • 3/2/2026Sanofi Secures Two New China Approvals for Dupilumab
  • 3/2/2026NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...
  • 3/2/2026MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China
  • 3/2/2026RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA
  • 3/2/20262026 Biotech Playbook: Hong Kong at the Centre of China's Globalisatio...
  • 2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
  • 2/28/2026Recent Executive Moves
  • 2/27/2026Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...
  • 2/26/2026China Accelerates Dementia Research to Challenge U.S. Leadership
  • 2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
  • 2/26/2026Jiuyuan Files for Approval of Wegovy Biosimilar in China
  • 2/26/2026China Pharmaceutical Market Projected to Reach US$573B by 2033
  • 2/26/2026U.S. ITC to Probe China's Trade Status and Biotech Practices
  • 2/26/2026China Expands Mutual Recognition of Medical Tests to Streamline Care a...
  • 2/26/2026China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...
  • 2/26/2026BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...
  • 2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...
  • 2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC
  • 2/25/2026China Schedules Antitrust Hearing in Abuse‑of‑Dominance Case Tied to...
  • 2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...
  • 2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...
  • 2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...
  • 2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer
  • Page:2/382 Total number of articles:11436: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group